DE520853C - Process for the production of ergosterol from yeast - Google Patents

Process for the production of ergosterol from yeast

Info

Publication number
DE520853C
DE520853C DEI33111D DEI0033111D DE520853C DE 520853 C DE520853 C DE 520853C DE I33111 D DEI33111 D DE I33111D DE I0033111 D DEI0033111 D DE I0033111D DE 520853 C DE520853 C DE 520853C
Authority
DE
Germany
Prior art keywords
ergosterol
yeast
production
separated
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEI33111D
Other languages
German (de)
Inventor
Dr Otto Ambros
Dr Erwin Walz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IG Farbenindustrie AG
Original Assignee
IG Farbenindustrie AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IG Farbenindustrie AG filed Critical IG Farbenindustrie AG
Priority to DEI33111D priority Critical patent/DE520853C/en
Application granted granted Critical
Publication of DE520853C publication Critical patent/DE520853C/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06Lysis of microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/02Monosaccharides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)

Description

Verfahren zur Gewinnung von Ergosterin aus Hefe In dem Patent 517 499 ist ein Verfahren zur Gewinnung von Sterinen aus Mikroorganismen oder Tier- oder Pflanzenteilen durch Extraktion beschrieben, bei dem man die genannten Ausgangsmaterialien einem enzymatischen Abbau unterwirft, durch den die Zellwandungen aufgelöst werden. Es wird auf diese Weise die Freilegung der zu gewinnenden Verbindungen aus ihren organischen Komplexen bedeutend erleichtert. Bei der Herstellung von Ergosterin, z. B. aus Hefe, wird durch die Autolyse der Zellkörper aufgelöst- und damit die nachfolgende chemische Behandlung mit alkoholischer Kalilauge sehr wirksam unterstützt.Process for obtaining ergosterol from yeast Patent 517 499 describes a process for obtaining sterols from microorganisms or parts of animals or plants by extraction, in which the starting materials mentioned are subjected to enzymatic degradation through which the cell walls are broken down. In this way, the exposure of the compounds to be obtained from their organic complexes is significantly facilitated. In the production of ergosterol, e.g. B. from yeast, is dissolved by the autolysis of the cell body and thus the subsequent chemical treatment with alcoholic potassium hydroxide is very effective.

Es wurde nun gefunden, daß nach diesem Verfahren in besonders vorteilhafter Weise Ergosterin aus Hefe gewonnen wird, wenn man die Hauptmenge des Ausgangsmaterials durch enzymatischen Abbau, zweckmäßig unter sterilen Bedingungen, in, wasserlösliche Verbindungen überführt, ohne Erhitzen der verflüssigten Masse von Odem ungelösten Rest abtrennt, und dann jedes der getrennten Produkte für sich auf die gewünschten Verbin-.dun,gen verarbeitet. Diese Arbeitsweise bietet den großen Vorteil, daß in dem unlöslichen Anteil das Ergosterin sich stark anreichert. Die Isolierung dies-er Verbindung läßt sich nunmehr mit einem bedeutend geringeren Aufwand an Reagenzien unter gleichzeitig vereinfachten Arbeitsbedingungen durchführen.It has now been found that this process is particularly advantageous Way ergosterol is obtained from yeast if you take the main amount of the starting material by enzymatic degradation, expediently under sterile conditions, in water-soluble Compounds transferred without heating the liquefied mass of undissolved edema The remainder is separated, and then each of the separated products is individually tailored to the desired Connect-.dun, gene processed. This mode of operation has the great advantage that in the insoluble part of the ergosterol accumulates strongly. The isolation of this-he Connection can now be made with a significantly lower expenditure of reagents carry out under simultaneously simplified working conditions.

Ein weiterer Vorteildes Verfahrens besteht darin, daß bei der obigen Arbeitsweise, unter Einhaltung einer Wasserstoffionenkonzentration pH = 6-7, von den Abbauprodukten der Hefe z. B. bestimmte Aminosäuren, wie Tyrosin, oder Purinderivate, wie Xanthin u. a., direkt in großer Reinheit in demselben Arbeitsgang als wertvolle Nebenprodukte anfallen.Another advantage of the process is that in the above procedure, while maintaining a hydrogen ion concentration of pH = 6-7, of the yeast degradation products, for. B. certain amino acids, such as tyrosine, or purine derivatives, such as xanthine and others. , Arise directly in high purity in the same operation as valuable by-products.

Beispiel 4ooo Gewichtsteile Preßhefe werden nach der Verflüssigung mit 8o Volumteilen Essigester durch Zufügen, von verdünntem Amnioniak auf eine Wasserstoffion#enkonzentratiOn PH - 6-7 gebracht. Nachdem das Autolysat mit weiteren 2o Volumteilen Essigester durchgeschüttelt wurde, bleibt es unter Gärverschluß sich selbst überlassen. Nach einigen Tagen ist der enzymatische Abbau der Zellsubstanz so weit fortgeschritten, daß Tyrosin sich abzuscheiden beginnt. Die grobkörnigen Kristallaggregate, etwa:2o Gewichtsteile, werden nun mit Hilfe eines engmaschigen Drahtsiebes abgetrennt. Die vom Tyrosin abgetrennte Autolysenflüssigkeit wird darauf zentrifugiert, um die nicht gelösten Anteile zu Z> gewinnen. Letztere bilden eine halbfeste Masse von etwa i ooo Volumteilen und enthalten das gesamte Ergosterin. Mit 4oo Gewichtsteilen Alkali und geringen Mengen Lösungsmitteln läßt sich nach kurzer Verseifung alles Ergosterin in freie Form bringen. Es wird in einer Ausbeute von etwa 14 Gewichtstellen als reines Präparat vom Schmelzpunkt 155 bis 1570 gewonnen.Example 4ooo parts by weight of pressed yeast after liquefaction with 8o Essigester parts by volume by the addition of dilute hydrogen Amnioniak a final concentration PH # - brought 6-7. After the autolysate has been shaken through with further 20 parts by volume of ethyl acetate, it is left to ferment under the fermentation seal. After a few days, the enzymatic breakdown of the cell substance has progressed so far that tyrosine begins to be deposited. The coarse-grained crystal aggregates, about: 2o parts by weight, are now separated off with the help of a close-meshed wire sieve. The separated from tyrosine Autolysenflüssigkeit is centrifuged out, win the parts not dissolved to Z>. The latter form a semi-solid mass of about 1,000 parts by volume and contain all of the ergosterol. With 400 parts by weight of alkali and small amounts of solvents, all ergosterol can be brought into free form after a short saponification. It is obtained in a yield of about 14 weight points as a pure preparation with a melting point of 155 to 1570 .

Die Verringerung des Aufwandes an Reagenzien beträgt, verglichen mit den sonst üblichen Darstellungsverfahren, 50 lo, #die Ausbentesteigerung an Ergosterin über i oo "/". Aus dem abgetrennten flüssigen Anteil können weitere wertvolle Stoffe, z. B. Leucin, leicht in größeren Mengen und nach bekannten Arbeitsweisen auch alle übrigen Hefespaltprodukte in guter Ausbeute gewonnen werden.The reduction in the expenditure of reagents compared with the otherwise customary preparation methods is 50 %, the increase in the yield of ergosterol over 10% "/". Other valuable substances such. B. leucine, easily in larger quantities and all other yeast cleavage products can be obtained in good yield according to known procedures.

Man kann auch so verfahren, daß man das angereicherte Rohprodukt zur Gewinnung der ErgQsterinkomponenten nach einer einfachen Entwässerung durch Veresterung, z. B. mittels Essigsäureanhydrids, in das Ergosterinacetat überführt, das durch seine ausgezeichnete Kristallisierharkeit leicht zu isolieren ist.One can also proceed in such a way that the enriched crude product is used Obtaining the ErgQsterol components after a simple dehydration by esterification, z. B. by means of acetic anhydride, converted into the ergosterol acetate, which is carried out by its excellent crystallizability is easy to isolate.

Claims (1)

PATENTANSPRUCII: Weitere Ausbildung ;des Verfahrens des Hauptpatents 517 499 zur Gewinnung von Ergosterin aus Hefe, dadurch gekennzeichnet, daß man die Hauptmenge des Ausgangsmaterials durch enzymatischen Ab-bau, zweckmäßig unter sterilen Bedingungen, in wasserlösliche Verbindungen überführt, ohne Erhitzen Ader verflüssigten Masse von,dem ungelösten Rest abtrennt, und hierauf jedesder getrennten Produkte für sich auf #die gewünschten Verbindungen verarbeitet.PATENT CLAIM: Further training; the process of the main patent 517 499 for the production of ergosterol from yeast, characterized in that the main amount of the starting material is converted into water-soluble compounds by enzymatic degradation, expediently under sterile conditions, without heating the liquefied mass of, separated from the undissolved residue, and then each of the separated products processed separately to # the desired compounds.
DEI33111D 1928-01-03 1928-01-03 Process for the production of ergosterol from yeast Expired DE520853C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEI33111D DE520853C (en) 1928-01-03 1928-01-03 Process for the production of ergosterol from yeast

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEI33111D DE520853C (en) 1928-01-03 1928-01-03 Process for the production of ergosterol from yeast

Publications (1)

Publication Number Publication Date
DE520853C true DE520853C (en) 1931-03-16

Family

ID=7188325

Family Applications (1)

Application Number Title Priority Date Filing Date
DEI33111D Expired DE520853C (en) 1928-01-03 1928-01-03 Process for the production of ergosterol from yeast

Country Status (1)

Country Link
DE (1) DE520853C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1060338B (en) * 1955-12-09 1959-07-02 Versuchs & Lehranstalt Process for the production of clearly soluble, slightly colored yeast extracts

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1060338B (en) * 1955-12-09 1959-07-02 Versuchs & Lehranstalt Process for the production of clearly soluble, slightly colored yeast extracts

Similar Documents

Publication Publication Date Title
DE520853C (en) Process for the production of ergosterol from yeast
DE884796C (en) Process for the preparation of N- [ª ‡ ', ª ‰' - Dioxy-ª ‰ ', ª ‰ -dimethyl-butyryl] -ª ‰ -alanine-ª ‰ "- mercapto-ethylamide
DE937056C (en) Process for the preparation of 5-pregnen-3ª ‰, 7ª ‡, 11ª ‡ -triol-20-one
DE954153C (en) Process for the preparation of 4-androstene-14 ª ‡ -o1-3, 17-dione
DE937051C (en) Process for the preparation of 3-ketobisnor-4-cholen-11ª ‡, 22-diol and or or 3-ketobisnor-4-cholentriol
DE937052C (en) Process for the preparation of 4-androstene-11ª ‡ -ol-3, 17-dione
DE725280C (en) Process for the preparation of compounds of the cyclopentanopolyhydrophenanthrene series
DE951444C (en) Process for the preparation of 4-pregnen-8, 17ª ‡, 21-triol-3, 20-dione
DE956955C (en) Process for the preparation of pregnan-and allopregnan-3ª ‡ -o1-11, 20-dione or of allopregnan-3ª ‰, 11ª ‡ diol-20-one
DE1195747B (en) Process for the production of new 16-methylene testosterone derivatives
DE699308C (en) Process for the production of polynuclear substituted ring ketones from sterols and bile acids
DE948686C (en) Process for the preparation of 4-pregnen-14ª ‡, 17ª ‡, 21-triol-3,20-dione
DE1418857C (en) Process for the production of 3beta-hydroxy- (or-acyloxy) -9alpha, llbeta-dichloro-lobeta-methyl-salphasteroids of the pregnane series
DE931770C (en) Process for the preparation of 17-oxypregnen- (5) -ol- (3) -one- (20)
DE956510C (en) Process for the production of 14ª ‡ -oxytestosterone or 14ª ‡ -oxy-10-normethyltestosterone
DE711823C (en) Process for the preparation of ketones of the cyclopentanonhydrophenanthrene series
DE937054C (en) Process for the preparation of 11á-oxy-6-dehydroprogesterone
DE884855C (en) Process for bio-oxidation of steroids of the adrenal cortex
DE709617C (en) Process for the preparation of AEtiocholylglyoxalen
DE882991C (en) Process for the preparation of 3-keto-17-oxy compounds of the androstane series
AT160622B (en) Process for the preparation of oxyoxo or polyoxy compounds of the cyclopentanopolyhydrophenanthrene series which do not contain any phenolic hydroxyl groups.
DE610306C (en) Process for the preparation of mixed anhydrides between boric and organic acids
AT216685B (en) Process for the preparation of steroids of the Δ <1,4> -Pregnadiene series
DE953976C (en) Process for the preparation of sterically uniform 17-methyloestradiol
DE1183079B (en) Process for the preparation of saturated 4-hydroxy-3-keto-5alpha-steroids